NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
10/21/2025
Back to search
Official data from USPTO
ATEA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ATEA PHARMACEUTICALS
ST13
US500000097018769Class
42
Filing
97018769
Registration
7009405
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/03/2026
Trademark type
Word
Nice classes
42
Filing date
09/09/2021
Registration date
03/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/21/2020
First use in commerce
10/21/2020
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
CLAYTON, CHERYL A
Current location
Historical data usage
Holders and representatives
Holders
Atea Pharmaceuticals, Inc.
Representatives
Theodore H. Davis Jr. KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research in the field of pharmaceuticals and development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
24 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/30/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/19/2025
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
09/16/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/22/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/03/2022
GNRT
NON-FINAL ACTION E-MAILED
06/03/2022
CNRT
NON-FINAL ACTION WRITTEN
06/03/2022
DOCK
ASSIGNED TO EXAMINER
05/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2021
NWAP
NEW APPLICATION ENTERED
09/13/2021
Continuous trademark protection
Get notified about every new filing that threatens ATEA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.